Patented Drug Extension Strategies on Healthcare Spending: A Cost-Evaluation Analysis

BACKGROUND: Drug manufacturers have developed “evergreening” strategies to compete with generic medication after patent termination. These include marketing of slightly modified follow-on drugs. We aimed to estimate the financial impact of these drugs on overall healthcare costs and also to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernaz, Nathalie, Haller, Guy, Girardin, François, Huttner, Benedikt, Combescure, Christophe, Dayer, Pierre, Muscionico, Daniel, Salomon, Jean-Luc, Bonnabry, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672218/
https://www.ncbi.nlm.nih.gov/pubmed/23750120
http://dx.doi.org/10.1371/journal.pmed.1001460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672218/
https://www.ncbi.nlm.nih.gov/pubmed/23750120
http://dx.doi.org/10.1371/journal.pmed.1001460

Ejemplares similares